BEIJING KAWIN TECHNOLOGY SHARE-HOLDING CO., LTD. Beijing Kawin Technology Share-Holding Co., Ltd.
Equities
688687
CNE1000054C3
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30.19 CNY | -0.30% |
|
-0.89% | -13.40% |
| 10/04 | China stocks down pressured by real estate; HK shares up | RE |
| 09/04 | Beijing Kawin Technology Share-Holding Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Beijing Kawin Technology Share-Holding Co Ltd is a China-based company principally engaged in the production and sales of therapeutic drugs in the viral disease field, and the research and development of innovative drugs. The Company's recombinant human interferon α2b and compound glycyrrhizin drugs are applied to treat viral diseases. The Company mainly distributes its products within domestic market.
Calendar
22/08/2024
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
30.19
CNY
Average target price
39.66
CNY
Spread / Average Target
+31.36%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -13.40% | 70Cr | |
| +9.42% | 11TCr | |
| +11.84% | 11TCr | |
| -1.05% | 2.2TCr | |
| -14.15% | 2.18TCr | |
| -5.29% | 1.92TCr | |
| -4.16% | 1.81TCr | |
| -38.29% | 1.77TCr | |
| +7.99% | 1.43TCr | |
| +36.24% | 1.24TCr |
- Stock Market
- Equities
- 688687 Stock
- News Beijing Kawin Technology Share-Holding Co., Ltd.
- Kawin Technology Gets Nod to Carry Out Trials Into Tumor Drug
